GlobeNewswire Inc | Aug 3, 2021 08:00AM EDT

August 03, 2021

TUCSON, Ariz., Aug. 03, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2021 after the market close on Thursday, August 12, 2021. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30 pm ET.

Conference Call & Webcast DetailsDate: Thursday, August 12Time: 4:30 pm ETToll Free: 877-407-0789International: 201-689-8562Conference ID: 13721188Webcast: http://public.viavid.com/index.php?id=145556

About HTGHTG is focused on NGS-based molecular profiling. The companys proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTGs customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.

Contact:Ashley R. RobinsonLifeSci Advisors, LLCPhone: (617) 430-7577Email:arr@lifesciadvisors.com